Pictet Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$97.9M Buy
187,240
+5,291
+3% +$2.53M 0.1% 217
2025
Q4
$106M Sell
181,949
-9,847
-5% -$5.03M 0.1% 213
2025
Q3
$87.7M Sell
191,796
-16,470
-8% -$6.14M 0.08% 234
2025
Q2
$63M Buy
208,266
+1,223
+0.6% +$364K 0.06% 279
2025
Q1
$68.5M Sell
207,043
-1,441
-0.7% -$473K 0.08% 256
2024
Q4
$64.3M Buy
208,484
+57,886
+38% +$16.3M 0.07% 261
2024
Q3
$32M Buy
150,598
+13,323
+10% +$3.41M 0.04% 378
2024
Q2
$38.5M Sell
137,275
-46,888
-25% -$11.2M 0.04% 328
2024
Q1
$48.4M Buy
184,163
+12,998
+8% +$3.06M 0.05% 314
2023
Q4
$39.6M Buy
171,165
+59,740
+54% +$10.5M 0.04% 346
2023
Q3
$16.3M Buy
+111,425
New +$21M 0.02% 513

Other funds holding MDGL